Compass Therapeutics, Inc. (CMPX) total debt

Total debt · fiscal 2025
$9.83M

Compass Therapeutics, Inc. (CMPX) carried total debt of $9.83M at the end of fiscal 2025 (December 31, 2025). That is 48.2% higher than the $6.63M of fiscal 2024. Figures as of 18 Nov 2026, 12:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$9.83M
Change on fiscal 2024
+48.2%
Growth, 5 years
+1.0% a year
Highest on record
$14.87Mfiscal 2019
Lowest on record
$0.00fiscal 2021
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Compass Therapeutics, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 1.0% a year. Across the 7 fiscal years on record (2019–2025), the highest was $14.87M in fiscal 2019 and the lowest $0.00 in fiscal 2021.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 7 fiscal years

Total debt by fiscal year

Compass Therapeutics, Inc. total debt, year by year

Compass Therapeutics, Inc. (CMPX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$9.83M 48.2% up0.0×
2024$6.63M 282.8% up0.1×
2023$1.73M 41.0% down0.0×
2022$2.94M—0.0×
2021$0.00 100.0% down0.0×
2020$9.33M 37.2% down0.2×
2019$14.87M—1.3×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on CMPX

Compass Therapeutics, Inc., figure by figure

Compass Therapeutics, Inc. (CMPX) overview: price, valuation and scorecard

Compass Therapeutics, Inc. total debt: questions and answers

How much debt does Compass Therapeutics, Inc. have?

Compass Therapeutics, Inc. (CMPX) carried total debt of $9.83M at the end of fiscal 2025 (December 31, 2025). That is 48.2% higher than the $6.63M of fiscal 2024.

What is the growth rate of Compass Therapeutics, Inc.'s total debt?

Over the five fiscal years to 2025 total debt grew at a compound 1.0% a year.

What are the highest and lowest total debt figures on record for Compass Therapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $14.87M in fiscal 2019 and the lowest $0.00 in fiscal 2021.

How does Compass Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Compass Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Compass Therapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Compass Therapeutics, Inc. (CMPX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/CMPX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.